Drug Type Small molecule drug |
Synonyms S2116 |
Target |
Action inhibitors |
Mechanism KDM1A inhibitors(Lysine-specific histone demethylase 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H25F2N3O2 |
InChIKeyCKUYVNUTAMQXJN-ABSDTBQOSA-N |
CAS Registry2262489-88-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | Japan | 06 May 2020 |